402 related articles for article (PubMed ID: 30975397)
1. Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
Hudgens S; Schüler R; Stokes J; Eremenco S; Hunsche E; Leist TP
Value Health; 2019 Apr; 22(4):453-466. PubMed ID: 30975397
[TBL] [Abstract][Full Text] [Related]
2. Meaningful Change Thresholds and Fatigue Severity Points on Patient-Reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire in Patients With Relapsing Multiple Sclerosis.
Hudgens S; Katz EG; Davies E; Keenan A; Sidorenko T; Jamieson C
Value Health; 2024 May; 27(5):598-606. PubMed ID: 38401796
[TBL] [Abstract][Full Text] [Related]
3. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
[TBL] [Abstract][Full Text] [Related]
4. Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS).
Ruotolo I; Sellitto G; Ianniello A; Petsas N; Castelli L; Galeoto G; Berardi A; Barletta V; Conte A; Pozzilli C
Neurol Sci; 2022 Aug; 43(8):4925-4932. PubMed ID: 35451663
[TBL] [Abstract][Full Text] [Related]
5. A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study.
Azoulai M; Lévy-Heidmann T; Morisseau V; Wilczynski O; Le HH; Jamieson C; Charvet LE; Krupp LB; Lair L
Mult Scler Relat Disord; 2022 Mar; 59():103637. PubMed ID: 35168093
[TBL] [Abstract][Full Text] [Related]
6. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial.
Wahls T; Scott MO; Alshare Z; Rubenstein L; Darling W; Carr L; Smith K; Chenard CA; LaRocca N; Snetselaar L
Trials; 2018 Jun; 19(1):309. PubMed ID: 29866196
[TBL] [Abstract][Full Text] [Related]
7. A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views.
Ziemssen T; Tolley C; Bennett B; Kilgariff S; Jones E; Pike J; Tomic D; Piani-Meier D; Lahoz R
Mult Scler Relat Disord; 2020 Feb; 38():101861. PubMed ID: 31865132
[TBL] [Abstract][Full Text] [Related]
8. Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.
Sellitto G; Ruotolo I; Ianniello A; Felicetti F; D'Ambrosi G; Berardi A; Galeoto G; Conte A; Pozzilli C
BMC Neurol; 2024 Apr; 24(1):138. PubMed ID: 38664640
[TBL] [Abstract][Full Text] [Related]
9. Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments.
Watson C; Scippa K; Barlev A; Kresa-Reahl K; Cole JC
Neurol Ther; 2022 Jun; 11(2):725-739. PubMed ID: 35266103
[TBL] [Abstract][Full Text] [Related]
10. The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection.
Kleinman L; Talbot GH; Hunsche E; Schüler R; Nord CE
Value Health; 2018 Apr; 21(4):441-448. PubMed ID: 29680101
[TBL] [Abstract][Full Text] [Related]
11. The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial.
Fox RJ; Tervonen T; Phillips-Beyer A; Sidorenko T; Boyanova N; Brooks A; Hennessy B; Jamieson C; Levitan B
Mult Scler; 2023 Mar; 29(3):427-435. PubMed ID: 36550636
[TBL] [Abstract][Full Text] [Related]
12. Validity and reliability of the multidimensional assessment of fatigue scale in Iranian patients with relapsing-remitting subtype of multiple sclerosis.
Behrangrad S; Kordi Yoosefinejad A
Disabil Rehabil; 2018 Mar; 40(6):673-677. PubMed ID: 28325094
[TBL] [Abstract][Full Text] [Related]
13. Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
Sumowski JF; Leavitt VM
Arch Phys Med Rehabil; 2014 Jul; 95(7):1298-302. PubMed ID: 24561056
[TBL] [Abstract][Full Text] [Related]
14. Correlation of self-assessed fatigue and alertness in multiple sclerosis.
Weinges-Evers N; Brandt AU; Bock M; Pfueller CF; Dörr J; Bellmann-Strobl J; Scherer P; Urbanek C; Boers C; Ohlraun S; Zipp F; Paul F
Mult Scler; 2010 Sep; 16(9):1134-40. PubMed ID: 20610494
[TBL] [Abstract][Full Text] [Related]
15. Qualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2).
Matza LS; Murray LT; Phillips GA; Konechnik TJ; Dennehy EB; Bush EN; Revicki DA
Patient; 2015 Oct; 8(5):433-43. PubMed ID: 25613915
[TBL] [Abstract][Full Text] [Related]
16. Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Hobart J; Cano S; Baron R; Thompson A; Schwid S; Zajicek J; Andrich D
Mult Scler; 2013 Nov; 19(13):1773-83. PubMed ID: 23574800
[TBL] [Abstract][Full Text] [Related]
17. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
19. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
